Newsletter Subject

2 Biotechs soar on new Alzheimer's data 🚀

From

elitetrade.club

Email Address

adam@elitetrade.club

Sent On

Mon, Jul 17, 2023 08:16 PM

Email Preheader Text

Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Happy Monday! It's July 17th. I hope

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Happy Monday! It's July 17th. I hope you had a great trading day! Here's what moved the market today: Markets 📈 Stocks closed the week's first trading session higher on Monday. The Dow [+0.2%] and S&P 500 [+0.3%] gained less than half a point, while the Nasdaq [+0.9%] outperformed. The small-cap Russell 2K [+1.1%] topped its large-cap cohorts. Sponsored [Get Free Buy, Sell, Hold Ratings]( Find out what a stock is really worth, how safe the stock is, and if the timing is right to buy. Plus a definitive Buy, Sell, Hold recommendation. [Analyze Any Stock Free]( Today's Market-Moving News 🔎 📉 Rout in Telecom Stocks Continues Legacy telecoms are reeling after a Wall Street Journal investigation into toxic lead cables culminated in an exposé article published on July 9th. Verizon [VZ -7.5%] and AT&T [T -6.6%] are hovering near multi-year lows in the wake of the damning report. Today's Top Winners and Losers 🔥 BYND Cannasoft Enterprises [BCAN] $1.34 (56.9%) priced a public offering of roughly 1.7 million shares for an expected gross proceed of $2.6 million. Jiuzi Holdings [JZXN] $1.51 (54.2%) made a securities purchase agreement with institutional investors for $2.3 million worth of its ordinary shares. Apellis Pharmaceuticals [APLS] $52.46 (37.9%) reported cases of retinal vasculitis have been observed from its Syfovre launch. 🚀 ProMIS Neurosciences [PMN] $6.19 (+120.2%) presented preclinical data supporting potential therapeutic advantage of its lead candidate for Alzheimer's Disease, PMN310. 🚀 BridgeBio Pharma [BBIO] $32.04 (+75.8%) said its experimental heart disease drug met its main goal in a late-stage study. Acumen Pharmaceuticals [ABOS] $9.72 (+54.7%) hosted a conference call to discuss positive topline results from a Phase 1 INTERCEPT-AD trial of its experimental Alzheimer's treatment. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... Text ELITE to 47121 to get our watchlists sent directly to your phone! You can also text CLOSE to 47121 to get the Closing Bell Roundup, too! *Standard message/carrier rates may apply. © Elite Trade Media LLC, 2023. All rights reserved. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. [Bots click here]( 1969 Alafaya Trail Suite #247 Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](

Marketing emails from elitetrade.club

View More
Sent On

08/12/2024

Sent On

07/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Sent On

03/12/2024

Sent On

03/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.